-
St. Cloud Financial Credit Union has a new leadership team member
St. Cloud Financial Credit Union has a new chief lending officer. Chase Larson has almost 15 years of banking and finance experience. He has expertise in mortgage lending, business banking and SBA lending, according to the company. “I am excited to get back to my credit union roots and work alongside the talented staff at St. Cloud Financial Credit Union serving their great members and communities,” Larson said. Larson is a St. Cloud Area Chamber of Commerce Top Hat Ambassador, a board member of St. Cloud Stand Down, a Sartell Chamber Blue Jacket Ambassador, a volunteer with United Way of
-
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021
ERYTECH Provides Business and Financial Update for the Third Quarter of 2021 Conference call and webcast on Tuesday, November 16, 2021at 8:30am EST / 2:30pm CET Progress towards seeking approval of eryaspase for the treatment of ALL patients who experienced hypersensitivity to pegylated asparaginase; Fast Track designation granted; submission of BLA intended around year-end Phase 3 trial in second–line pancreatic cancer did not meet its primary endpoint Process to review strategic options and partnering alternatives launched Cambridge, MA (U.S.) and Lyon (France), November 15, 2021 – ERYTECH Pharma (Nasdaq
-
Euroclear Business and Financial update
BRUSSELS, Oct. 29, 2021 /CNW/ — Financial highlights Q3 YTD 2021 operating income up 9% year-on-year to EUR 1156 million as strong Business Income growth offset lower Banking and Other Income Operating costs increased by 6% to EUR 676 million, including exceptional costs related to the MFEX acquisition Net profit increased by 11% to EUR 347 million EPS increased 11% to EUR 110.3 per share Euroclear logo (PRNewsfoto/Euroclear) Key Operating Metrics remain strong Assets under custody reached EUR 36.1 trillion an increase of 15% year on year Record number of netted transactions settled in the Euroclear group of
-
NOXXON Reports H1 2021 Financial Results and Provides Business Update
Positive results from two cohorts of Phase 1/2 clinical trial with NOX-A12 in brain cancer; full readout expected in Q1 2022 Appointment of Scientific Advisory Board with top US and EU pancreatic cancer experts Appointment of 3 new Supervisory Board members with remarkable experience Strengthening the Company’s balance sheet by raising a total of €9.3 million ensuring financial visibility into June 2022 BERLIN, October 22, 2021–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announces its financial results and business highlights
-
A Formula For Driving Business Growth While Balancing Your Personal And Financial Life
Scott Snider is the President of Exit Planning Institute, the authority on Exit Planning education. Getty For a business owner, a notable difference exists between generating a successful net profit or annual income and building significant value. A seemingly nice balance sheet and annual profit and loss statement does not imply a company is valuable. As the president of a company that provides professional advisors with the content, tools and training needed to guide business owners, I’ve seen how focusing on building value today can help protect your business against unforeseeable future crises. Additionally, this can help ensure the
The Go-To Source For Marvelous Servise
/https://specials-images.forbesimg.com/imageserve/5eda4ed34a0fa20006cf423a/0x0.jpg)